Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 97Leukemia, Lymphocytic, Chronic, B-Cell 88Lymphoma, Follicular 81Lymphoma 62Lymphoma, Mantle-Cell 59Lymphoma, B-Cell, Marginal Zone 47Lymphoma, Non-Hodgkin 46Recurrence 35Lymphoma, B-Cell 24Leukemia 20Waldenstrom Macroglobulinemia 18Hodgkin Disease 18Lymphoma, T-Cell, Peripheral 16Burkitt Lymphoma 14Lymphoma, T-Cell, Cutaneous 12Lymphoma, T-Cell 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Sezary Syndrome 10Mycosis Fungoides 10Multiple Myeloma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Large-Cell, Anaplastic 9Immunoblastic Lymphadenopathy 8Lymphoma, Large-Cell, Immunoblastic 7Intraocular Lymphoma 7Neoplasms 6Lymphoma, Extranodal NK-T-Cell 6Leukemia, B-Cell 6Leukemia, Hairy Cell 5Leukemia-Lymphoma, Adult T-Cell 4

Interventions

Brentuximab Vedotin 4Bexarotene 2iratumumab 1Vitamin B 12 1Salvia hispanica seed extract 1Methotrexate 1Lenalidomide 1Folic Acid 1Cholecalciferol 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Primary Cutaneous Anaplastic Large Cell × Lenalidomide × Lymphoid × Clear all
NCT03409432 2025-07-25

Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
26 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphomatoid Papulosis, Lymphoma, Primary Cutaneous Anaplastic Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡